|
Sign In to gain access to subscriptions and/or personal tools.
|
How Effective Is Enteral Nutrition in Inducing Clinical Remission in Active Crohn's Disease? A Meta-Analysis of the Randomized Clinical Trials
Fernando Fernández-Bañares, MD
Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
Eduard Cabré, MD
Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
Maria Esteve-Comas, MD
Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
Miquel A. Gassull, MD
Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
Background: The purpose of the study was to evaluate, using meta-analysis techniques, whether enteral nutrition is effective in inducing clinical remission in active Crohn's disease. Methods: Randomized trials either comparing enteral nutrition with steroids or comparing elemental (amino acid-based) with nonelemental diets were selected using MEDLINE (1984 to 1994), reference lists from published articles, reviews, and abstracts from major gastrointestinal meetings. Sixteen studies fulfilled the inclusion criteria (four published as abstracts). Crude rates for induction of remission were collected on an intention-to-treat basis by three independent observers. Each study was given a quality score, based on predetermined criteria. Results: The pooled odds ratio (OR) for all type of enteral diets compared with steroid therapy was 0.35 (95% CI, 0.23 to 0.53). This result was similar for the best studies (by quality score) combined, for trials using tube feeding combined, and when noncompliant patients were withdrawn. Further subgroup analyses were conducted on the basis of the type of diet administered. Peptide-based diets were significantly inferior to steroids (pooled OR, 0.32; CI, 0.20 to 0.52). There was a trend to lower remission rate after elemental diets than after steroids (pooled OR, 0.44; CI 0.17 to 1.12). On the other hand, pooled OR for whole protein-based diets compared with elemental diets was 1.28 (CI, 0.40 to 4.02). Conclusions: Data available to date show that steroids are better than enteral nutrition to induce remission in active Crohn's disease. These results are more evident when peptide-based diets are administered, but they are not conclusive when either elemental or whole protein-based diets are used. (journal of Parenteral and Enteral Nutrition 19:356-364, 1995)
Journal of Parenteral and Enteral Nutrition, Vol. 19, No. 5,
356-364 (1995)
DOI: 10.1177/0148607195019005356
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
R. L. Koretz
Enteral Nutrition: A Hard Look at Some Soft Evidence
Nutr Clin Pract,
June 1, 2009;
24(3):
316 - 324.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Mane, E. Pedrosa, V. Loren, I. Ojanguren, L. Fluvia, E. Cabre, G. Rogler, and M. A. Gassull
Partial Replacement of Dietary (n-6) Fatty Acids with Medium-Chain Triglycerides Decreases the Incidence of Spontaneous Colitis in Interleukin-10-Deficient Mice
J. Nutr.,
March 1, 2009;
139(3):
603 - 610.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. El-Matary
Enteral Nutrition as a Primary Therapy of Crohn's Disease: The Pediatric Perspective
Nutr Clin Pract,
February 1, 2009;
24(1):
91 - 97.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Issa and D. G. Binion
Bowel Rest and Nutrition Therapy in the Management of Active Crohn's Disease
Nutr Clin Pract,
June 1, 2008;
23(3):
299 - 308.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A F Rodrigues, T Johnson, P Davies, and M S Murphy
Does polymeric formula improve adherence to liquid diet therapy in children with active Crohn's disease?
Arch. Dis. Child.,
September 1, 2007;
92(9):
767 - 770.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. E. Wiskin, S. A. Wootton, and R. M. Beattie
Nutrition Issues in Pediatric Crohn's Disease
Nutr Clin Pract,
April 1, 2007;
22(2):
214 - 222.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T Johnson, S Macdonald, S M Hill, A Thomas, and M S Murphy
Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial
Gut,
March 1, 2006;
55(3):
356 - 361.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L.-E. Tiengou, R. Gloro, J. Pouzoulet, K. Bouhier, M.-H. Read, F. Arnaud-Battandier, J.-M. Plaze, X. Blaizot, T. Dao, and M.-A. Piquet
Semi-Elemental Formula or Polymeric Formula: Is There a Better Choice for Enteral Nutrition in Acute Pancreatitis? Randomized Comparative Study
JPEN J Parenter Enteral Nutr,
January 1, 2006;
30(1):
1 - 5.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Griffiths
Enteral Nutrition in the Management of Crohn's Disease
JPEN J Parenter Enteral Nutr,
July 1, 2005;
29(4_suppl):
S108 - S117.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M. Beattie
Enteral Nutrition as Primary Therapy in Childhood Crohn's Disease: Control of Intestinal Inflammation and Anabolic Response
JPEN J Parenter Enteral Nutr,
July 1, 2005;
29(4_suppl):
S151 - S159.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Dray and P. Marteau
The Use of Enteral Nutrition in the Management of Crohn's Disease in Adults
JPEN J Parenter Enteral Nutr,
July 1, 2005;
29(4_suppl):
S166 - S172.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Gassull, J. Mane, E. Pedrosa, and E. Cabre
Macronutrients and Bioactive Molecules: Is There a Specific Role in the Management of Inflammatory Bowel Disease?
JPEN J Parenter Enteral Nutr,
July 1, 2005;
29(4_suppl):
S179 - S183.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. L. Koretz
Is Statistical Significance Always Significant?
Nutr Clin Pract,
June 1, 2005;
20(3):
303 - 307.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M J Carter, A J Lobo, and S P L Travis
Guidelines for the management of inflammatory bowel disease in adults
Gut,
September 1, 2004;
53(suppl_5):
v1 - v16.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M A Gassull, F Fernandez-Banares, E Cabre, M Papo, M H Giaffer, J L Sanchez-Lombrana, C Richart, H Malchow, F Gonzalez-Huix, and M Esteve
Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial
Gut,
August 1, 2002;
51(2):
164 - 168.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
American Society for Parenteral and Enteral Nutrit
Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients
JPEN J Parenter Enteral Nutr,
January 1, 2002;
26(1_suppl):
1SA - 138SA.
[PDF]
|
|
|
|
|
|
|
M. Esteve-Comas and M. A. Gassull
Abnormal fatty acid status in patients with Crohn disease
Am. J. Clinical Nutrition,
March 1, 2001;
73(3):
661 - 662.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Klein, J. Kinney, K. Jeejeebhoy, D. Alpers, M. Hellerstein, M. Murray, and P. Twomey
Nutrition Support in Clinical Practice: Review of Published Data and Recommendations for Future Research Directions: Summary of a Conference Sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition
JPEN J Parenter Enteral Nutr,
May 1, 1997;
21(3):
133 - 156.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. Bernier
Clarification Needed
JPEN J Parenter Enteral Nutr,
September 1, 1996;
20(5):
379 - 380.
[PDF]
|
|
|
|
|
